Industry Growth Insights published a new data on “Non-opioid Pain Patch Market”. The research report is titled “Non-opioid Pain Patch Market research by Types (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others), By Applications (Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores), By Players/Companies Acorda Therapeutics, ALLERGAN, Endo International, GlaxoSmithKline, Hisamitsu Pharmaceutical, IBSA Institut Biochimque, Mylan, Pfizer, TEH SENG Pharmaceutical Mfg, Teikoku Seiyaku”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-opioid Pain Patch Market Research Report
By Type
Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others
By Application
Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores
By Companies
Acorda Therapeutics, ALLERGAN, Endo International, GlaxoSmithKline, Hisamitsu Pharmaceutical, IBSA Institut Biochimque, Mylan, Pfizer, TEH SENG Pharmaceutical Mfg, Teikoku Seiyaku
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Non-opioid Pain Patch Market Report Segments:
The global Non-opioid Pain Patch market is segmented on the basis of:
Types
Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Acorda Therapeutics
- ALLERGAN
- Endo International
- GlaxoSmithKline
- Hisamitsu Pharmaceutical
- IBSA Institut Biochimque
- Mylan
- Pfizer
- TEH SENG Pharmaceutical Mfg
- Teikoku Seiyaku
Highlights of The Non-opioid Pain Patch Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lidocaine Patches
- Diclofenac Patches
- Methyl Salicylate Patches
- Capsaicin Patches
- Ketoprofen Patches
- Others
- By Application:
- Hospital Pharmacies
- Online Pharmacies
- Independent Pharmacies & Drug Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-opioid Pain Patch Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-opioid pain patches are a type of medication that is used to relieve pain. They work by blocking the receptors in the brain that are responsible for sending signals of pain.
Some of the major players in the non-opioid pain patch market are Acorda Therapeutics, ALLERGAN, Endo International, GlaxoSmithKline, Hisamitsu Pharmaceutical, IBSA Institut Biochimque, Mylan, Pfizer, TEH SENG Pharmaceutical Mfg, Teikoku Seiyaku.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-opioid Pain Patch Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-opioid Pain Patch Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-opioid Pain Patch Market - Supply Chain
4.5. Global Non-opioid Pain Patch Market Forecast
4.5.1. Non-opioid Pain Patch Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-opioid Pain Patch Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-opioid Pain Patch Market Absolute $ Opportunity
5. Global Non-opioid Pain Patch Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-opioid Pain Patch Market Size and Volume Forecast by Type
5.3.1. Lidocaine Patches
5.3.2. Diclofenac Patches
5.3.3. Methyl Salicylate Patches
5.3.4. Capsaicin Patches
5.3.5. Ketoprofen Patches
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-opioid Pain Patch Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-opioid Pain Patch Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Online Pharmacies
6.3.3. Independent Pharmacies & Drug Stores
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-opioid Pain Patch Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-opioid Pain Patch Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-opioid Pain Patch Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-opioid Pain Patch Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-opioid Pain Patch Demand Share Forecast, 2019-2026
9. North America Non-opioid Pain Patch Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-opioid Pain Patch Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-opioid Pain Patch Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Online Pharmacies
9.4.3. Independent Pharmacies & Drug Stores
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-opioid Pain Patch Market Size and Volume Forecast by Type
9.7.1. Lidocaine Patches
9.7.2. Diclofenac Patches
9.7.3. Methyl Salicylate Patches
9.7.4. Capsaicin Patches
9.7.5. Ketoprofen Patches
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-opioid Pain Patch Demand Share Forecast, 2019-2026
10. Latin America Non-opioid Pain Patch Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-opioid Pain Patch Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-opioid Pain Patch Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Online Pharmacies
10.4.3. Independent Pharmacies & Drug Stores
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-opioid Pain Patch Market Size and Volume Forecast by Type
10.7.1. Lidocaine Patches
10.7.2. Diclofenac Patches
10.7.3. Methyl Salicylate Patches
10.7.4. Capsaicin Patches
10.7.5. Ketoprofen Patches
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-opioid Pain Patch Demand Share Forecast, 2019-2026
11. Europe Non-opioid Pain Patch Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-opioid Pain Patch Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-opioid Pain Patch Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Online Pharmacies
11.4.3. Independent Pharmacies & Drug Stores
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-opioid Pain Patch Market Size and Volume Forecast by Type
11.7.1. Lidocaine Patches
11.7.2. Diclofenac Patches
11.7.3. Methyl Salicylate Patches
11.7.4. Capsaicin Patches
11.7.5. Ketoprofen Patches
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-opioid Pain Patch Demand Share, 2019-2026
12. Asia Pacific Non-opioid Pain Patch Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-opioid Pain Patch Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-opioid Pain Patch Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Online Pharmacies
12.4.3. Independent Pharmacies & Drug Stores
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-opioid Pain Patch Market Size and Volume Forecast by Type
12.7.1. Lidocaine Patches
12.7.2. Diclofenac Patches
12.7.3. Methyl Salicylate Patches
12.7.4. Capsaicin Patches
12.7.5. Ketoprofen Patches
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-opioid Pain Patch Demand Share, 2019-2026
13. Middle East & Africa Non-opioid Pain Patch Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-opioid Pain Patch Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-opioid Pain Patch Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Online Pharmacies
13.4.3. Independent Pharmacies & Drug Stores
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-opioid Pain Patch Market Size and Volume Forecast by Type
13.7.1. Lidocaine Patches
13.7.2. Diclofenac Patches
13.7.3. Methyl Salicylate Patches
13.7.4. Capsaicin Patches
13.7.5. Ketoprofen Patches
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-opioid Pain Patch Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-opioid Pain Patch Market: Market Share Analysis
14.2. Non-opioid Pain Patch Distributors and Customers
14.3. Non-opioid Pain Patch Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Acorda Therapeutics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ALLERGAN
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Endo International
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GlaxoSmithKline
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hisamitsu Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. IBSA Institut Biochimque
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mylan
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. TEH SENG Pharmaceutical Mfg
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Teikoku Seiyaku
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook